在热和化疗选择压力下,高风险软组织肉瘤的基因组进化
Maren Schmiester1,2, Antonia Freytag1, Bernhard Gillissen1
1Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
概括
区域性高温症与化疗相结合会改变肉瘤遗传学. 在治疗后观察到组素H3修饰基因的突变,这表明在软组织肉瘤中治疗协同作用的生物基础.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
背景情况:
- 区域性高热改善了高风险软组织肉瘤的生存率.
- 这种多模式治疗的遗传和生物效应尚不清楚.
- 了解治疗中的瘤演变可以指导治疗策略.
研究的目的:
- 为了研究用化疗和区域性高温治疗的软组织肉瘤中的基因组变化.
- 在联合治疗选择压力下探索瘤进化模式.
主要方法:
- 在治疗前和治疗后的患者的配对肉瘤样本上进行了整体外体序列测序.
- 分析包括来自12名患者的9个配对样本和3个治疗后样本.
主要成果:
- 在所有配对样本中观察到具有基因组转移的瘤进化.
- 变化在很大程度上是瘤特异性的,但在治疗后发现了基因组H3修饰基因的反复突变.
- 这些发现表明,在联合疗法下,瘤的基因组进化模式多样化.
结论:
- 这项研究突出了在结合化疗和高热症下沙尔科马的多样化基因组进化.
- 基因组 H3 基因的突变为这种联合治疗的协同作用提供了生物学证据.
- 治疗反应可能取决于瘤的特定遗传组成.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


